These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 35372462)

  • 1. Identification of Prostate Cancer Risk Genetics Biomarkers Based on Intergraded Bioinformatics Analysis.
    Liang X; Wang Y; Pei L; Tan X; Dong C
    Front Surg; 2022; 9():856446. PubMed ID: 35372462
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of ARHGEF38, NETO2, GOLM1, and SAPCD2 Associated With Prostate Cancer Progression by Bioinformatic Analysis and Experimental Validation.
    Sun Z; Mao Y; Zhang X; Lu S; Wang H; Zhang C; Xiao C; Cao Y; Qing Y; Wang Y; Li K
    Front Cell Dev Biol; 2021; 9():718638. PubMed ID: 34540835
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exploring the role of differentially expressed metabolic genes and their mechanisms in bone metastatic prostate cancer.
    Zhang Q; Zhang P; Zhao Z; Wang J; Zhang H
    PeerJ; 2023; 11():e15013. PubMed ID: 37070095
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Histone lysine methylation patterns in prostate cancer microenvironment infiltration: Integrated bioinformatic analysis and histological validation.
    Quan Y; Zhang X; Wang M; Ping H
    Front Oncol; 2022; 12():981226. PubMed ID: 36237332
    [TBL] [Abstract][Full Text] [Related]  

  • 5. EpCAM as a Novel Biomarker for Survivals in Prostate Cancer Patients.
    Liao Y; Wu M; Jia Y; Mou R; Li X
    Front Cell Dev Biol; 2022; 10():843604. PubMed ID: 35517503
    [No Abstract]   [Full Text] [Related]  

  • 6. Identification of Potential Key Genes for Pathogenesis and Prognosis in Prostate Cancer by Integrated Analysis of Gene Expression Profiles and the Cancer Genome Atlas.
    Liu S; Wang W; Zhao Y; Liang K; Huang Y
    Front Oncol; 2020; 10():809. PubMed ID: 32547947
    [No Abstract]   [Full Text] [Related]  

  • 7. Role of CXCR4 as a Prognostic Biomarker Associated With the Tumor Immune Microenvironment in Gastric Cancer.
    Gu Y; Gu W; Xie R; Chen Z; Xu T; Fei Z
    Front Cell Dev Biol; 2021; 9():654504. PubMed ID: 34568309
    [No Abstract]   [Full Text] [Related]  

  • 8. LTBP2 inhibits prostate cancer progression and metastasis via the PI3K/AKT signaling pathway.
    Zhang X; Tian C; Cheng J; Mao W; Li M; Chen M
    Exp Ther Med; 2022 Sep; 24(3):563. PubMed ID: 36034756
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Construction and analysis of mRNA, miRNA, lncRNA, and TF regulatory networks reveal the key genes associated with prostate cancer.
    Ye Y; Li SL; Wang SY
    PLoS One; 2018; 13(8):e0198055. PubMed ID: 30138363
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Identification of Key Gene Expression Signature in Prostate Cancer.
    Huang Y; Cao Q; Song Z; Ruan H; Wang K; Chen K; Zhang X
    Crit Rev Eukaryot Gene Expr; 2020; 30(2):153-168. PubMed ID: 32558494
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of Pathologic and Prognostic Genes in Prostate Cancer Based on Database Mining.
    Liu K; Chen Y; Feng P; Wang Y; Sun M; Song T; Tan J; Li C; Liu S; Kong Q; Zhang J
    Front Genet; 2022; 13():854531. PubMed ID: 35360870
    [No Abstract]   [Full Text] [Related]  

  • 12. Arecoline Is Associated With Inhibition of Cuproptosis and Proliferation of Cancer-Associated Fibroblasts in Oral Squamous Cell Carcinoma: A Potential Mechanism for Tumor Metastasis.
    Li J; Chen S; Liao Y; Wang H; Zhou D; Zhang B
    Front Oncol; 2022; 12():925743. PubMed ID: 35875097
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor Expression Profile Analysis Developed and Validated a Prognostic Model Based on Immune-Related Genes in Bladder Cancer.
    Dong B; Liang J; Li D; Song W; Zhao S; Ma Y; Song J; Zhu M; Yang T
    Front Genet; 2021; 12():696912. PubMed ID: 34512722
    [No Abstract]   [Full Text] [Related]  

  • 14. Integrated bioinformatics analysis for differentially expressed genes and signaling pathways identification in gastric cancer.
    Yang C; Gong A
    Int J Med Sci; 2021; 18(3):792-800. PubMed ID: 33437215
    [No Abstract]   [Full Text] [Related]  

  • 15. A Novel Set of Immune-associated Gene Signature predicts Biochemical Recurrence in Localized Prostate Cancer Patients after Radical Prostatectomy.
    Luan JC; Zhang QJ; Zhao K; Zhou X; Yao LY; Zhang TT; Zeng TY; Xia JD; Song NH
    J Cancer; 2021; 12(12):3715-3725. PubMed ID: 33995646
    [No Abstract]   [Full Text] [Related]  

  • 16. miR-93-5p may be an important oncogene in prostate cancer by bioinformatics analysis.
    Yang Y; Jia B; Zhao X; Wang Y; Ye W
    J Cell Biochem; 2019 Jun; 120(6):10463-10483. PubMed ID: 30582208
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of a Prognostic Signature Model with Tumor Microenvironment for predicting Disease-free Survival after Radical Prostatectomy.
    Zhao H; Zhang X; Shi Z; Guo B; Zhang W; He K; Hu X; Shi S
    J Cancer; 2021; 12(8):2371-2384. PubMed ID: 33758613
    [No Abstract]   [Full Text] [Related]  

  • 18. Predictions of the dysregulated competing endogenous RNA signature involved in the progression of human lung adenocarcinoma.
    Yang D; He Y; Wu B; Liu R; Wang N; Wang T; Luo Y; Li Y; Liu Y
    Cancer Biomark; 2020; 29(3):399-416. PubMed ID: 32741804
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immune and Stroma Related Genes in Breast Cancer: A Comprehensive Analysis of Tumor Microenvironment Based on the Cancer Genome Atlas (TCGA) Database.
    Xu M; Li Y; Li W; Zhao Q; Zhang Q; Le K; Huang Z; Yi P
    Front Med (Lausanne); 2020; 7():64. PubMed ID: 32195260
    [No Abstract]   [Full Text] [Related]  

  • 20. Bioinformatics Analysis Finds Immune Gene Markers Related to the Prognosis of Bladder Cancer.
    Chen X; Jin Y; Gong L; He D; Cheng Y; Xiao M; Zhu Y; Wang Z; Cao K
    Front Genet; 2020; 11():607. PubMed ID: 32655621
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.